Nike, Inc. - Class B logo

Nike, Inc. - Class B (NKE)

Market Open
23 Jul, 15:54
NYSE NYSE
$
40. 84
-1.38
-3.2575%
$
64.76B Market Cap
27.8 P/E Ratio
1.64% Div Yield
6.36M Volume
3.76 Eps
$ 42.21
Previous Close
Add Transaction
Day Range
40.83 42.08
Year Range
40 80.17
Want to track NKE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nike to lay off about 1% of corporate staff in its latest effort to refocus the business

Nike to lay off about 1% of corporate staff in its latest effort to refocus the business

Nike is planning to lay off less than 1% of its corporate staff. The move is part of CEO Elliott Hill's efforts to realign how teams are structured across the business.

Cnbc | 10 months ago
NIKE's Premium P/E & Fresh Rally: Time to Accumulate or Stay Cautious?

NIKE's Premium P/E & Fresh Rally: Time to Accumulate or Stay Cautious?

NKE's rally under its Win Now reset fuels optimism, but lofty valuations and near-term headwinds keep investors cautious.

Zacks | 11 months ago
Nike (NKE) Exceeds Market Returns: Some Facts to Consider

Nike (NKE) Exceeds Market Returns: Some Facts to Consider

In the most recent trading session, Nike (NKE) closed at $78.38, indicating a +2.89% shift from the previous trading day.

Zacks | 11 months ago
NIKE vs. Deckers: Which Athletic Footwear Stock Holds More Promise?

NIKE vs. Deckers: Which Athletic Footwear Stock Holds More Promise?

DECK builds momentum with HOKA and UGG growth and global expansion, while NKE faces revenue pressure and China weakness.

Zacks | 11 months ago
Nike Defying The Sellside's Bearish Outlook, Eyeing A Breakout Into Earnings

Nike Defying The Sellside's Bearish Outlook, Eyeing A Breakout Into Earnings

Nike is rebounding with a new CEO, improved tariff clarity, and a focus on core strengths, despite mixed retail sector earnings. Q4 earnings beat expectations, and technical indicators point to a bullish setup, with a potential breakout target near $108 per share. Valuation remains attractive, as shares trade below historical averages, offering about 10% upside to normalized fair value.

Seekingalpha | 11 months ago
NIKE's Classic Franchises Fade: Can Fresh Launches Drive Recovery?

NIKE's Classic Franchises Fade: Can Fresh Launches Drive Recovery?

NKE faces a $1B hit from fading classics but bets on fresh launches and sport-led innovation to spark recovery.

Zacks | 11 months ago
NIKE: Patience Will Be Rewarded

NIKE: Patience Will Be Rewarded

Despite near-term EPS headwinds and China/wholesale uncertainty, I reiterate my Buy rating on Nike for long-term investors. Short-term challenges, including tariffs and negative EPS revisions, are likely temporary. Nike's strong ROCE and reinvestment rates support double-digit long-term growth even under my more conservative projections.

Seekingalpha | 11 months ago
NIKE vs. Skechers: Which Player is Ahead in the Global Footwear Race?

NIKE vs. Skechers: Which Player is Ahead in the Global Footwear Race?

NKE emphasizes innovation and cultural scale, while SKX expands globally with comfort and value-driven growth.

Zacks | 11 months ago
Nike (NKE) Stock Declines While Market Improves: Some Information for Investors

Nike (NKE) Stock Declines While Market Improves: Some Information for Investors

Nike (NKE) closed the most recent trading day at $76.39, moving 1.05% from the previous trading session.

Zacks | 11 months ago
“What do you say when somebody says they want to give you $2 billion?” Nike co-founder Phil Knight makes a record donation.

“What do you say when somebody says they want to give you $2 billion?” Nike co-founder Phil Knight makes a record donation.

Knight and his wife are making a record private gift to Oregon Health & Science University amid broader battles over public funding for higher education.

Wsj | 11 months ago
Nike co-founder Phil Knight to donate $2 billion to OHSU cancer institute

Nike co-founder Phil Knight to donate $2 billion to OHSU cancer institute

The Knight Foundation said the gift that will be used to shift the scientific approach to cancer treatment, research and patient care outcomes.

Cnbc | 11 months ago
Nike co-founder Phil Knight to donate $2 billion to University of Oregon's Cancer Institute

Nike co-founder Phil Knight to donate $2 billion to University of Oregon's Cancer Institute

Nike co-founder Phil Knight is donating $2 billion to the Oregon Health and Science University's Cancer Institute. The Knight Foundation says it's the single largest donation ever to a U.S. university, college or health institution.

Cnbc | 11 months ago
Loading...
Load More